LC1501a : Lung cancer tissue array with different types of lung cancer and normal lung tissue, (2021 WHO classification), including pathology grade, TNM and clinical stage (AJCC 8th edition), 75 cases/150 cores (core size 1.0mm), replacing LC1501
|
Microarray Panel | Lung carcinoma microarray with different types lung cancer and normal lung tissue, containing 39 cases of lung adenocarcinoma, 22 squamous cell carcinoma, 5 small cell carcinoma, 3 atypical carcinoid, 1 each of lung mucoepidermoid carcinoma, plus 5 normal lung tissue, duplicate cores per case | |
Cores | 150 | |
Cases | 75 | |
Row number | 10 | |
Column number | 15 | |
Core Diameter (mm) | 1 | |
Thickness (µm) | 5 | |
Quality Control | H&E and IHC confirmed | |
Tissue Array Type | FFPE | |
Species | Human | |
Applications | Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page. | |
Notes | 1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours. In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers. |
Mouseover and click individual cores to view high resolution images.
Legend: |
|
Specification Sheet (Sortable), tissue IDs are available in exported Excel files.
Pos. | No. | Age | Sex | Organ/Anatomic Site | Pathology diagnosis | TNM | Grade | Stage | Type | Image |
---|
A1 | 1 | 47 | F | Papillary adenocarcinoma | T2aN0M0 | 1 | IB | malignant | ||
A2 | 2 | 74 | M | Acinar adenocarcinoma | T2bN0M0 | 1 | IIA | malignant | ||
A3 | 3 | 72 | F | Acinar adenocarcinoma | T3N1M0 | 1 | IIIA | malignant | ||
A4 | 4 | 69 | M | Lepid adenocarcinoma | T1cN0M0 | 1 | IC | malignant | ||
A5 | 5 | 50 | F | Acinar adenocarcinoma | T2bN1M0 | 1 | IIB | malignant | ||
A6 | 6 | 65 | F | Acinar adenocarcinoma | T2aN0M0 | 1 | IB | malignant | ||
A7 | 7 | 63 | F | Papillary adenocarcinoma | T2aN1M0 | 2 | IIB | malignant | ||
A8 | 8 | 63 | F | Acinar adenocarcinoma | T4N3M0 | 2 | IIIC | malignant | ||
A9 | 9 | 64 | M | Acinar adenocarcinoma | T1cN0M0 | 2 | IC | malignant | ||
A10 | 10 | 73 | M | Acinar adenocarcinoma | T3N0M0 | 2 | IIB | malignant | ||
A11 | 11 | 61 | F | Acinar adenocarcinoma | T2aN1M0 | 2 | IIB | malignant | ||
A12 | 12 | 57 | M | Papillary adenocarcinoma | T2aN1M0 | 2 | IIB | malignant | ||
A13 | 13 | 66 | M | Invasive mucinous adenocarcinoma | T3N0M0 | 2 | IIB | malignant | ||
A14 | 14 | 69 | M | Acinar adenocarcinoma | T2aN0M0 | 2 | IB | malignant | ||
A15 | 15 | 52 | M | Adenocarcinoma,enteric type (lung tissue) | T2aN1M0 | * | IIB | malignant | ||
B1 | 16 | 47 | F | Papillary adenocarcinoma | T2aN0M0 | 1 | IB | malignant | ||
B2 | 17 | 74 | M | Acinar adenocarcinoma | T2bN0M0 | 1 | IIA | malignant | ||
B3 | 18 | 72 | F | Acinar adenocarcinoma | T3N1M0 | 1 | IIIA | malignant | ||
B4 | 19 | 69 | M | Lepid adenocarcinoma (lung tissue) | T1cN0M0 | * | IC | malignant | ||
B5 | 20 | 50 | F | Acinar adenocarcinoma | T2bN1M0 | 1 | IIB | malignant | ||
B6 | 21 | 65 | F | Acinar adenocarcinoma (sparse) | T2aN0M0 | 1 | IB | malignant | ||
B7 | 22 | 63 | F | Papillary adenocarcinoma | T2aN1M0 | 2 | IIB | malignant | ||
B8 | 23 | 63 | F | Acinar adenocarcinoma | T4N3M0 | 2 | IIIC | malignant | ||
B9 | 24 | 64 | M | Acinar adenocarcinoma | T1cN0M0 | 2 | IC | malignant | ||
B10 | 25 | 73 | M | Acinar adenocarcinoma | T3N0M0 | 2 | IIB | malignant | ||
B11 | 26 | 61 | F | Acinar adenocarcinoma | T2aN1M0 | 2 | IIB | malignant | ||
B12 | 27 | 57 | M | Papillary adenocarcinoma | T2aN1M0 | 2 | IIB | malignant | ||
B13 | 28 | 66 | M | Invasive mucinous adenocarcinoma | T3N0M0 | 2 | IIB | malignant | ||
B14 | 29 | 69 | M | Acinar adenocarcinoma | T2aN0M0 | 2 | IB | malignant | ||
B15 | 30 | 52 | M | Adenocarcinoma,enteric type | T2aN1M0 | 2 | IIB | malignant | ||
C1 | 31 | 52 | F | Acinar adenocarcinoma | T2bN1M0 | 2 | IIB | malignant | ||
C2 | 32 | 59 | F | Acinar adenocarcinoma | T3N0M0 | 2 | IIB | malignant | ||
C3 | 33 | 77 | F | Acinar adenocarcinoma | T2bN1M0 | 2 | IIB | malignant | ||
C4 | 34 | 73 | M | Acinar adenocarcinoma | T2bN0M0 | 2 | IIA | malignant | ||
C5 | 35 | 54 | M | Acinar adenocarcinoma | T3N0M0 | 2 | IIB | malignant | ||
C6 | 36 | 70 | M | Acinar adenocarcinoma | T2aN0M0 | 2 | IB | malignant | ||
C7 | 37 | 67 | M | Acinar adenocarcinoma | T2aN0M0 | 2 | IB | malignant | ||
C8 | 38 | 51 | M | Adenocarcinoma,enteric type | T2bN2M0 | 2 | IIIA | malignant | ||
C9 | 39 | 55 | F | Acinar adenocarcinoma | T2aN0M0 | 2 | IB | malignant | ||
C10 | 40 | 55 | F | Acinar adenocarcinoma | T2bN1M0 | 2 | IIB | malignant | ||
C11 | 41 | 56 | F | Acinar adenocarcinoma | T2bN3M0 | 2 | IIIB | malignant | ||
C12 | 42 | 70 | M | Acinar adenocarcinoma | T2aN1M0 | 2 | IIB | malignant | ||
C13 | 43 | 71 | M | Acinar adenocarcinoma | T2aN0M0 | 2 | IB | malignant | ||
C14 | 44 | 69 | M | Solid adenocarcinoma | T4N0M0 | 3 | IIIA | malignant | ||
C15 | 45 | 57 | M | Solid adenocarcinoma | T4N1M0 | 3 | IIIA | malignant | ||
D1 | 46 | 52 | F | Acinar adenocarcinoma (lung tissue) | T2bN1M0 | * | IIB | malignant | ||
D2 | 47 | 59 | F | Acinar adenocarcinoma | T3N0M0 | 2 | IIB | malignant | ||
D3 | 48 | 77 | F | Acinar adenocarcinoma | T2bN1M0 | 2 | IIB | malignant | ||
D4 | 49 | 73 | M | Acinar adenocarcinoma | T2bN0M0 | 2 | IIA | malignant | ||
D5 | 50 | 54 | M | Acinar adenocarcinoma with necrosis | T3N0M0 | 2 | IIB | malignant | ||
D6 | 51 | 70 | M | Acinar adenocarcinoma | T2aN0M0 | 2 | IB | malignant | ||
D7 | 52 | 67 | M | Acinar adenocarcinoma | T2aN0M0 | 2 | IB | malignant | ||
D8 | 53 | 51 | M | Adenocarcinoma,enteric type | T2bN2M0 | 2 | IIIA | malignant | ||
D9 | 54 | 55 | F | Acinar adenocarcinoma (sparse) | T2aN0M0 | 2 | IB | malignant | ||
D10 | 55 | 55 | F | Acinar adenocarcinoma | T2bN1M0 | 2 | IIB | malignant | ||
D11 | 56 | 56 | F | Acinar adenocarcinoma | T2bN3M0 | 2 | IIIB | malignant | ||
D12 | 57 | 70 | M | Acinar adenocarcinoma | T2aN1M0 | 2 | IIB | malignant | ||
D13 | 58 | 71 | M | Acinar adenocarcinoma | T2aN0M0 | 2 | IB | malignant | ||
D14 | 59 | 69 | M | Solid adenocarcinoma | T4N0M0 | 3 | IIIA | malignant | ||
D15 | 60 | 57 | M | Solid adenocarcinoma | T4N1M0 | 3 | IIIA | malignant | ||
E1 | 61 | 56 | M | Acinar adenocarcinoma | T2bN1M0 | 3 | IIB | malignant | ||
E2 | 62 | 47 | M | Solid adenocarcinoma | T2aN0M0 | 3 | IB | malignant | ||
E3 | 63 | 59 | M | Acinar adenocarcinoma | T2bN3M0 | 3 | IIIB | malignant | ||
E4 | 64 | 55 | M | Solid adenocarcinoma | T2aN3M0 | 3 | IIIB | malignant | ||
E5 | 65 | 57 | M | Solid adenocarcinoma | T2bN0M0 | 3 | IIA | malignant | ||
E6 | 66 | 63 | M | Papillary adenocarcinoma | T2bN0M0 | 3 | IIA | malignant | ||
E7 | 67 | 27 | M | Acinar adenocarcinoma | T3N2M0 | 3 | IIIB | malignant | ||
E8 | 68 | 69 | M | Squamous cell carcinoma,keratinizing | T3N0M0 | 2 | IIB | malignant | ||
E9 | 69 | 75 | M | Squamous cell carcinoma,keratinizing | T2bN1M0 | 2 | IIB | malignant | ||
E10 | 70 | 63 | M | Squamous cell carcinoma,keratinizing | T2bN1M0 | 2 | IIB | malignant | ||
E11 | 71 | 55 | M | Squamous cell carcinoma,nonkeratinizing | T3N0M0 | 3 | IIB | malignant | ||
E12 | 72 | 56 | M | Squamous cell carcinoma,nonkeratinizing | T3N0M0 | 3 | IIB | malignant | ||
E13 | 73 | 54 | F | Squamous cell carcinoma,keratinizing | T3N1M0 | 2 | IIIA | malignant | ||
E14 | 74 | 55 | M | Squamous cell carcinoma,nonkeratinizing | T4N1M0 | 2 | IIIA | malignant | ||
E15 | 75 | 75 | M | Squamous cell carcinoma,nonkeratinizing | T1cN1M0 | 2 | IIB | malignant | ||
F1 | 76 | 56 | M | Acinar adenocarcinoma | T2bN1M0 | 3 | IIB | malignant | ||
F2 | 77 | 47 | M | Solid adenocarcinoma | T2aN0M0 | 3 | IB | malignant | ||
F3 | 78 | 59 | M | Acinar adenocarcinoma | T2bN3M0 | 3 | IIIB | malignant | ||
F4 | 79 | 55 | M | Solid adenocarcinoma | T2aN3M0 | 3 | IIIB | malignant | ||
F5 | 80 | 57 | M | Solid adenocarcinoma | T2bN0M0 | 3 | IIA | malignant | ||
F6 | 81 | 63 | M | Papillary adenocarcinoma | T2bN0M0 | 3 | IIA | malignant | ||
F7 | 82 | 27 | M | Acinar adenocarcinoma | T3N2M0 | 3 | IIIB | malignant | ||
F8 | 83 | 69 | M | Squamous cell carcinoma,keratinizing | T3N0M0 | 2 | IIB | malignant | ||
F9 | 84 | 75 | M | Squamous cell carcinoma,keratinizing | T2bN1M0 | 2 | IIB | malignant | ||
F10 | 85 | 63 | M | Squamous cell carcinoma,keratinizing | T2bN1M0 | 2 | IIB | malignant | ||
F11 | 86 | 55 | M | Squamous cell carcinoma,nonkeratinizing | T3N0M0 | 3 | IIB | malignant | ||
F12 | 87 | 56 | M | Squamous cell carcinoma,nonkeratinizing | T3N0M0 | 3 | IIB | malignant | ||
F13 | 88 | 54 | F | Squamous cell carcinoma,keratinizing | T3N1M0 | 2 | IIIA | malignant | ||
F14 | 89 | 55 | M | Squamous cell carcinoma,nonkeratinizing | T4N1M0 | 2 | IIIA | malignant | ||
F15 | 90 | 75 | M | Squamous cell carcinoma,nonkeratinizing | T1cN1M0 | 2 | IIB | malignant | ||
G1 | 91 | 65 | M | Basoloid squamous cell carcinoma | T2bN0M0 | 3 | IIA | malignant | ||
G2 | 92 | 57 | M | Squamous cell carcinoma,nonkeratinizing | T3N3M0 | 3 | IIIC | malignant | ||
G3 | 93 | 63 | M | Squamous cell carcinoma,keratinizing | T3N0M0 | 2 | IIB | malignant | ||
G4 | 94 | 57 | M | Squamous cell carcinoma,keratinizing | T3N0M0 | 2 | IIB | malignant | ||
G5 | 95 | 64 | F | Squamous cell carcinoma,keratinizing | T3N1M0 | 1 | IIIA | malignant | ||
G6 | 96 | 64 | M | Squamous cell carcinoma,keratinizing | T2aN0M0 | 1 | IB | malignant | ||
G7 | 97 | 63 | M | Squamous cell carcinoma,keratinizing | T2aN0M0 | 1 | IB | malignant | ||
G8 | 98 | 69 | M | Squamous cell carcinoma,nonkeratinizing | T4N0M0 | 3 | IIIA | malignant | ||
G9 | 99 | 51 | F | Squamous cell carcinoma,nonkeratinizing | T4N3M0 | 3 | IIIC | malignant | ||
G10 | 100 | 57 | M | Squamous cell carcinoma,nonkeratinizing | T2bN1M0 | 3 | IIB | malignant | ||
G11 | 101 | 48 | M | Squamous cell carcinoma,nonkeratinizing | T2bN0M0 | 3 | IIA | malignant | ||
G12 | 102 | 68 | M | Squamous cell carcinoma,keratinizing | T2aN0M0 | 3 | IB | malignant | ||
G13 | 103 | 70 | M | Squamous cell carcinoma,nonkeratinizing | T3N0M0 | 3 | IIB | malignant | ||
G14 | 104 | 61 | M | Squamous cell carcinoma,nonkeratinizing | T3N0M0 | 3 | IIB | malignant | ||
G15 | 105 | 67 | M | Small cell carcinoma | T2aN0M0 | - | IB | malignant | ||
H1 | 106 | 65 | M | Basoloid squamous cell carcinoma | T2bN0M0 | 2 | IIA | malignant | ||
H2 | 107 | 57 | M | Squamous cell carcinoma,nonkeratinizing | T3N3M0 | 2 | IIIC | malignant | ||
H3 | 108 | 63 | M | Squamous cell carcinoma,keratinizing | T3N0M0 | 2 | IIB | malignant | ||
H4 | 109 | 57 | M | Squamous cell carcinoma,keratinizing | T3N0M0 | 2 | IIB | malignant | ||
H5 | 110 | 64 | F | Squamous cell carcinoma,keratinizing (necrosis) | T3N1M0 | * | IIIA | malignant | ||
H6 | 111 | 64 | M | Squamous cell carcinoma,keratinizing | T2aN0M0 | 2 | IB | malignant | ||
H7 | 112 | 63 | M | Squamous cell carcinoma,keratinizing | T2aN0M0 | 2 | IB | malignant | ||
H8 | 113 | 69 | M | Squamous cell carcinoma,nonkeratinizing (fibrous adipose tissue) | T4N0M0 | * | IIIA | malignant | ||
H9 | 114 | 51 | F | Squamous cell carcinoma,nonkeratinizing | T4N3M0 | 3 | IIIC | malignant | ||
H10 | 115 | 57 | M | Squamous cell carcinoma,nonkeratinizing | T2bN1M0 | 3 | IIB | malignant | ||
H11 | 116 | 48 | M | Squamous cell carcinoma,nonkeratinizing | T2bN0M0 | 3 | IIA | malignant | ||
H12 | 117 | 68 | M | Squamous cell carcinoma,keratinizing | T2aN0M0 | 3 | IB | malignant | ||
H13 | 118 | 70 | M | Squamous cell carcinoma,nonkeratinizing | T3N0M0 | 3 | IIB | malignant | ||
H14 | 119 | 61 | M | Squamous cell carcinoma,nonkeratinizing | T3N0M0 | 3 | IIB | malignant | ||
H15 | 120 | 67 | M | Small cell carcinoma | T2aN0M0 | 3 | IB | malignant | ||
I1 | 121 | 58 | M | Small cell carcinoma | T2aN0M0 | - | IB | malignant | ||
I2 | 122 | 53 | M | Small cell carcinoma | T4N1M0 | - | IIIA | malignant | ||
I3 | 123 | 62 | M | Small cell carcinoma | T2bN1M0 | - | IIB | malignant | ||
I4 | 124 | 47 | M | Small cell carcinoma | T1cN0M0 | - | IA3 | malignant | ||
I5 | 125 | 54 | M | Atypical carcinoid | T2aN0M0 | - | IB | malignant | ||
I6 | 126 | 65 | M | Atypical carcinoid | T2bN0M0 | - | IIA | malignant | ||
I7 | 127 | 35 | M | Atypical carcinoid | T2aN1M0 | - | IIB | malignant | ||
I8 | 128 | 78 | M | Mucoepidermoid carcinoma | T3N1M0 | - | IIIA | malignant | ||
I9 | 129 | 59 | M | Colloid adenocarcinoma | T2bN1M0 | - | IIB | malignant | ||
I10 | 130 | 55 | F | Solid adenocarcinoma | T2bN0M0 | - | IIA | malignant | ||
I11 | 131 | 45 | F | Lung tissue | - | - | - | normal | ||
I12 | 132 | 40 | F | Lung tissue | - | - | - | normal | ||
I13 | 133 | 21 | F | Lung tissue | - | - | - | normal | ||
I14 | 134 | 48 | M | Lung tissue | - | - | - | normal | ||
I15 | 135 | 24 | M | Lung tissue | - | - | - | normal | ||
J1 | 136 | 58 | M | Small cell carcinoma | T2aN0M0 | - | IB | malignant | ||
J2 | 137 | 53 | M | Small cell carcinoma | T4N1M0 | - | IIIA | malignant | ||
J3 | 138 | 62 | M | Small cell carcinoma | T2bN1M0 | - | IIB | malignant | ||
J4 | 139 | 47 | M | Small cell carcinoma | T1cN0M0 | - | IA3 | malignant | ||
J5 | 140 | 54 | M | Atypical carcinoid | T2aN0M0 | - | IB | malignant | ||
J6 | 141 | 65 | M | Atypical carcinoid | T2bN0M0 | - | IIA | malignant | ||
J7 | 142 | 35 | M | Atypical carcinoid | T2aN1M0 | - | IIB | malignant | ||
J8 | 143 | 78 | M | Mucoepidermoid carcinoma | T3N1M0 | - | IIIA | malignant | ||
J9 | 144 | 59 | M | Colloid adenocarcinoma | T2bN1M0 | - | IIB | malignant | ||
J10 | 145 | 55 | F | Solid adenocarcinoma | T2bN0M0 | - | IIA | malignant | ||
J11 | 146 | 45 | F | Lung tissue | - | - | - | normal | ||
J12 | 147 | 40 | F | Lung tissue | - | - | - | normal | ||
J13 | 148 | 21 | F | Lung tissue | - | - | - | normal | ||
J14 | 149 | 48 | M | Lung tissue | - | - | - | normal | ||
J15 | 150 | 24 | M | Lung tissue | - | - | - | normal | ||
- | 0 | 42 | M | Adrenal gland | Pheochromocytoma (tissue marker) | - | Malignant |
Find overlapping cases with this tissue array:
- Product Code: LC1501a
- Availability: In Stock